What’s Vulnerable › Vulnerabilities
CVE-2026-21974
- Severity: medium (CVSS 5.3 v3.1)
- Exploited in the wild: not listed in CISA KEV
- EPSS: 0.3% probability of exploitation in the next 30 days
- Public exploit or detection template: none known
- Published: 2026-01-20 · updated 2026-06-17
- Weakness: CWE-200
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Affected products
References
Get alerted when CVE-2026-21974 or the next vulnerability affects your stack